Search alternatives:
significant decrease » significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
significant decrease » significantly increased (Expand Search)
significant fold » significant force (Expand Search), significant co (Expand Search), significant all (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
-
781
Centrifuged FMT products consistently exhibit the lowest median log<sub>10</sub> drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log<sub>10</sub> drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing....
Published 2025“…Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. …”
-
782
BFD2 aggravates the inflammatory response to <i>Toxoplasma gondii</i> infection.
Published 2025Subjects: -
783
-
784
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
785
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
786
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
787
Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX
Published 2024“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”
-
788
-
789
-
790
-
791
Reasons for the determination of blood culture contamination for each organism.
Published 2024Subjects: -
792
-
793
-
794
Semiannual analysis of monthly use of skin disinfection swab sets in the hospital.
Published 2024Subjects: -
795
-
796
-
797
-
798
-
799
-
800